tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Talphera’s Niyad Study: A Potential Game-Changer in Renal Therapy
PremiumCompany AnnouncementsTalphera’s Niyad Study: A Potential Game-Changer in Renal Therapy
1M ago
Talphera Holds Annual Meeting with Key Decisions
Premium
Company Announcements
Talphera Holds Annual Meeting with Key Decisions
1M ago
Talphera Regains Nasdaq Compliance After Grace Period
Premium
Company Announcements
Talphera Regains Nasdaq Compliance After Grace Period
1M ago
Talphera, Inc. Earnings Call Highlights Strategic Progress
PremiumCompany AnnouncementsTalphera, Inc. Earnings Call Highlights Strategic Progress
3M ago
Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trial
Premium
The Fly
Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trial
3M ago
Positive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position
Premium
Ratings
Positive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position
4M ago
Talphera’s Strategic Advancements and Financial Stability Reinforce Buy Rating
PremiumRatingsTalphera’s Strategic Advancements and Financial Stability Reinforce Buy Rating
7M ago
Talphera, Inc. Earnings Call: Strategic Adjustments and Financial Progress
Premium
Company Announcements
Talphera, Inc. Earnings Call: Strategic Adjustments and Financial Progress
7M ago
Talphera, Inc. Reports Q1 2025 Financial Results
Premium
Company Announcements
Talphera, Inc. Reports Q1 2025 Financial Results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100